Drugmaker Johnson & Johnson's share prices have risen following an order for the company to pay $572m (£468m) for its role in the opioid addiction crisis.
Center For Disease Control And Prevention
1-1 of 1 Articles
Drugmaker Johnson & Johnson's share prices have risen following an order for the company to pay $572m (£468m) for its role in the opioid addiction crisis.